Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2010
05/25/2010US7723055 Using aberration in wingless (WNT) gene expression as evaluating tool in diagnosis/prognosis of cell proliferative disorders
05/25/2010US7723054 Toll-like receptor 9 modulators
05/25/2010US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators
05/25/2010US7723049 Marker for inflammatory conditions
05/25/2010US7723044 Methods and apparatus for detection of viral infection
05/25/2010US7723041 Assay for SARS coronavirus by amplification and detection of the replicase sequence
05/25/2010US7723040 Detection of HIV-1 by nucleic acid amplification
05/25/2010US7723039 Gene expression profiling from FFPE samples
05/25/2010US7723038 Amplification methods
05/25/2010US7723037 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory disease
05/25/2010US7723036 determining that a human will have a prolonged response period to treatment of follicular lymphoma with Rituximab monoclonal antibody therapy; examining either protein or nucleic acids
05/25/2010US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells
05/25/2010US7723034 determining that a single nucleotide point mutation in the fourth exon of the nucleic acid sequence encoding dog CLN5 results in the production of a variant soluble lysosomal glycoprotein, specifically CLN5, which exhibits aberrant functional activity
05/25/2010US7723033 Prediction of likelihood of cancer recurrence
05/25/2010US7723031 replication and amplification of target nucleic acid sequences, in the presence of a bacteriophage protein and a DNA polymerase; genetic engineering
05/25/2010US7723030 Diagnosis and treatment of cancers with microRNA located in or near cancer associated chromosomal features
05/25/2010US7723029 Biochips including ion transport detecting structures and methods of use
05/25/2010US7723028 Diagnostics and therapeutics for osteoporosis
05/25/2010US7723027 Using presence of mutation in neuronal sodium channel (SCN1) to diagnose severe myoclonic epilepsy of infancy (SMEI)
05/25/2010US7723026 diagnosis and prognosis of cancer, based on the detection of 5-methylcytosine in DNA; by converting unmethylated cytosine of DNA to uracil, hybridizing with oligonucleotides, cleaving, amplifying, detecting the amplificates; bioassay
05/25/2010US7723025 detecting in the nucleic acids the presence of an A allele of a bovine stearoyl-CoA desaturase (SCD) gene to determine which bovine animal has high grade of meat, a higher percentage of monounsaturated fatty acid
05/25/2010US7723024 by measuring zinc regulated nucleic acid molecules expression level indicative of sub-optimal fermentation in a beer brewing
05/25/2010US7723023 Solid substrate comprising immobilized oligonuclelotides to identify all genes activated by specific signal transduction pathway for screening drugs which modulate diabetes, cancer, psychological, pain and gastrointestinal disorders
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7723021 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases
05/25/2010US7723020 Use of azetidinone compounds
05/25/2010US7723019 Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof
05/25/2010US7723018 Identifying compounds which inhibit cell cycle progression for use in treating cell proliferative disorders agents for treat; antiproliferative/antitumor agents
05/25/2010US7722928 Nanolithography methods and products therefor and produced thereby
05/25/2010US7722880 polynucleotide encodes a protein for inducing an immune response; use as vaccines; drug targeting to specific protein; bactericides; veterinary medicine
05/25/2010US7722875 Antibodies that bind canine pancreatic lipase
05/25/2010US7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof
05/25/2010US7722864 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system
05/25/2010US7722835 Closed reaction vessel system
05/25/2010US7721412 Method of making an electrochemical sensor
05/25/2010CA2488697C Regulation of gene expression using chromatin remodelling factors
05/25/2010CA2469393C Processes for the measurement of the potency of glatiramer acetate
05/25/2010CA2468275C Assaying apparatus, kit, and method for lipids and associated enzymes
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2330237C Broad specificity dna damage endonuclease
05/25/2010CA2248243C Purification of tissue plasminogen activator (tpa)
05/25/2010CA2241786C Novel amp activated protein kinase
05/25/2010CA2233538C Commercial production of aprotinin in plants
05/25/2010CA2225189C Canine factor viii gene, protein and methods of use
05/20/2010WO2010057185A1 Phospholink nucleotides for sequencing applications
05/20/2010WO2010057152A2 Cross-species chimeric rna molecules
05/20/2010WO2010057135A2 Methods and compositions for predicting a subject's susceptibility to and risk of developing type 2 diabetes
05/20/2010WO2010057132A1 Genetic alterations associated with schizophrenia and methods of use thereof for the diagnosis and treatment of the same
05/20/2010WO2010057112A2 Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets
05/20/2010WO2010057108A1 Imprinting in very small embryonic-like (vsel) stem cells
05/20/2010WO2010057097A1 A system useful for reporting protein-protein interactions in the bacterial periplasm
05/20/2010WO2010057078A2 Method and system for generating spatially and temporally controllable concentration gradients
05/20/2010WO2010057069A1 Compositions, kits and methods for detection campylobacter nucleic acid
05/20/2010WO2010057005A2 Apparatus and method for detecting glycol
05/20/2010WO2010056993A2 Prostate cancer biomarkers to predict recurrence and metastatic potential
05/20/2010WO2010056982A2 Compositions and methods for identifying autism spectrum disorders
05/20/2010WO2010056966A2 Novel hiv-2 isolate
05/20/2010WO2010056931A1 Methods for identification of tumor phenotype and treatment
05/20/2010WO2010056897A1 Autism associated genetic markers
05/20/2010WO2010056858A2 Bioluminescence imaging-based screening assay and inhibitors of abcg2
05/20/2010WO2010056755A2 Microfluidic embryo and gamete culture systems
05/20/2010WO2010056747A1 Prognostic test for early stage non small cell lung cancer (nsclc)
05/20/2010WO2010056709A2 Eimeria vaccine for turkeys
05/20/2010WO2010056645A2 Methods for genotyping mature cotton fibers and textiles
05/20/2010WO2010056642A2 Methods for genetic analysis of textiles made of gossypium barbadense and gossypium hirsutum cotton
05/20/2010WO2010056579A1 Methods and compositions in particle-based detection of target molecules using covalent bond forming reactive pairs
05/20/2010WO2010056577A1 Methods and compositions in particle-based detection of target molecules using linking molecules
05/20/2010WO2010056513A2 Products and processes for multiplex nucleic acid identification
05/20/2010WO2010056506A1 Diacylglycerol aclytransferase inhibitors
05/20/2010WO2010056499A1 Individually synthesized primers to be used in whole genome amplification
05/20/2010WO2010056406A1 Use of erbb4 as a prognostic and therapeutic marker for melanoma
05/20/2010WO2010056399A1 Method and composition for modulating the immune system and various inflammatory conditions comprising complement depletors
05/20/2010WO2010056374A2 Methods and compositions of molecular profiling for disease diagnostics
05/20/2010WO2010056351A2 Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia
05/20/2010WO2010056337A2 Methods and systems of using exosomes for determining phenotypes
05/20/2010WO2010056229A1 Nutritional supplements and their methods of formulation
05/20/2010WO2010056131A1 A method and system for analysing data sequences
05/20/2010WO2010056115A1 Bulked mutant analysis (bma)
05/20/2010WO2010056107A2 Method for identification of a molecular marker linked to the shell gene of oil palm
05/20/2010WO2010056053A2 Method for predicting activation energy using an atomic fingerprint descriptor or an atomic descriptor
05/20/2010WO2010056012A2 Method for quantifying skin changes caused by six external evils and method for screening skin condition-improving materials using the same
05/20/2010WO2010055916A1 Method for quantitatively determining cholesterol in low-density lipoproteins, reagent for quantitative determination, and quantitative determination kit
05/20/2010WO2010055868A1 Method for detecting bacterium belonging to genus geosmithia
05/20/2010WO2010055867A1 Method for determining therapeutic effect of reperfusion therapy
05/20/2010WO2010055829A1 Method and kit for detecting biological signal of three-dimensional cell culture material
05/20/2010WO2010055789A1 Oligonucleotide derivative, labeling agent, and use of the labeling agent
05/20/2010WO2010055525A1 Method for predicting a patient's responsiveness to anti-folate therapy
05/20/2010WO2010055488A2 Compositions and methods for micro-rna expession profiling of hepatocellular cancer
05/20/2010WO2010055487A2 Compositions and methods for micro-rna expession profiling of colorectal cancer
05/20/2010WO2010055467A1 Method for the urinary detection of bladder cancer.
05/20/2010WO2010055395A1 Biomarker for diagnosing cancer
05/20/2010WO2010055307A1 Methods of enhancing translocation of charged analytes through transmembrane protein pores
05/20/2010WO2010055184A1 Method and kit for hepatitis e virus (hev) detection
05/20/2010WO2010055183A1 Method for cell identification and quantification with gold nanoparticles through hydrogen ion reduction
05/20/2010WO2010055147A1 Efficient detection of double mutants of the cebpa gene in acute myeloid leukemia
05/20/2010WO2010055134A1 Rna detection method
05/20/2010WO2010055109A2 Novel product and processes
05/20/2010WO2010054819A1 Method for the specific detection of low abundance rna species in a biological sample
05/20/2010WO2010054806A1 X-chromosomal variation as a diagnostic and therapeutic marker for the progression to aids
05/20/2010WO2010054589A1 Detection of hla genotype
1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 3003